Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Clinical
Phase IV
Phase IV
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase IV
First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar Gel (Repository Corticotropin Injection) for Severe Keratitis
Firstwordpharma News
-
December 16, 2019
- Advertisement -
MOST POPULAR
ASH19: Pfizer, Sangamo’s haemophilia A gene therapy SB-525 continues to show...
December 9, 2019
Foamix Announces Enrollment Completion of Phase 2 Acne Clinical Trial for...
November 18, 2019
BeiGene Announces Phase 1 Long-Term Exposure Data and Results from Structural...
April 1, 2019
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25...
March 27, 2019
Load more
HOT NEWS
Commercial
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) –...
Others
Getting to the Root of the Disease: Developing Drugs Against the...
Others
BioSpace Global Roundup, Dec. 26
Clinical
Kiadis Pharma announces FDA clearance of clinical study by The Ohio...
